1upHealth Named a ‘Cool Vendor in Healthcare Interoperability’ by Gartner for its FHIR Platform

BOSTON, June 24, 2020 /PRNewswire/ — 1upHealth was just named a ‘Cool Vendor’, in Gartner’s Cool Vendors in Healthcare Interoperability, a publication spotlighting companies that have innovative approaches in electronic health data interoperability. In the report, Gartner says “1upHealth’s FHIR Platform is the first true implementation of the ONC’s intent for healthcare interoperability.”

The Boston-based company 1upHealth helps health insurance plans, healthcare providers, application developers, and patients interact with electronic health records via FHIR Application Programming Interfaces (APIs). FHIR, which is becoming an evermore important standard in national healthcare policy, is a new standard that brings the data transmission protocols commonly used behind websites and mobile applications into the healthcare industry. Recently, ONC and CMS introduced new regulations to support the CMS Final Rules for Interoperability and Patient Access. This rule requires health insurance companies to make their claims and clinical data available as FHIR APIs to 3rd-party applications directly via patient authorization; this is one of the most significant regulations affecting health plans in the last decade and has been years in the making.

Due to 1upHealth’s FHIR experience (noted by numerous government awards in FHIR server security, health data provenance, and consumer health) health insurance payers are looking to 1up to support more than just the CMS rules. In a recent conference on the new rules, Ricky Sahu, CEO of 1upHealth, said “These new regulations offer a rare opportunity for health plans and payers to build the foundation for the future of healthcare and support a set of unbundled apps on a common API platform.”

1up has notable customers including top National Health Plans, Boston Children’s Hospital, MassMutual, IBM, FDA, Vertex, and hundreds of healthcare application vendors covering all major sectors of the healthcare industry. The company got its start enabling aggregation and sharing of patient medical data from over 10,000+ health systems under the Meaningful Use regulations which requires health systems to support the same 3rd-party application access via FHIR. Today 1upHealth’s network covers over 280 million patients throughout the U.S.

Healthcare incentives are shifting towards value based care instead of fee for service. With additional data transparency offered by standard APIs, the federal government is hoping to reduce healthcare costs and improve quality for government regulated plans. Ultimately these APIs will unlock data access to creative problem solvers outside the direct walls of the healthcare system and lead to broader customer choice and personalization.

For more information, email hello@1up.health or visit https://1up.health.

CONTACT:  Khristina Butenko, khristina@1up.health

View original content:http://www.prnewswire.com/news-releases/1uphealth-named-a-cool-vendor-in-healthcare-interoperability-by-gartner-for-its-fhir-platform-301082360.html

SOURCE 1upHealth

Staff

Recent Posts

Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences

The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…

13 mins ago

High-Growth Industries with 25%-30% CAGR Growth Over the Next Five Years

BCC Research Identifies Key Sectors with Substantial Growth Potential, Forecasting Significant Market Expansion Through 2029.…

14 mins ago

Bioz Brings Cutting-Edge AI Citation Widgets to Precision X-Ray, Inc.’s Product Pages

PALO ALTO, CA / ACCESSWIRE / July 3, 2024 / Bioz, Inc., a pioneering AI…

14 mins ago

iZafe Group Receives Confirmed Order of 500 Dosell Units from Ti Medi

STOCKHOLM, SWEDEN / ACCESSWIRE / July 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…

14 mins ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…

3 hours ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation…

3 hours ago